LTBR

Mestag Presents Preclinical Data at AACR on its M300 Program, a Conditionally Active LTBR Agonist Designed to Induce Tertiary Lymphoid Structures in Tumors

Retrieved on: 
Monday, April 8, 2024
Research, TLS, FAP, Survival, Patient, Doctor of Philosophy, AACR, Neoplasm, Therapy, LTBR, M300, Pharmaceutical industry

The poster titled “Conditionally active, therapeutic lymphotoxin beta receptor (LTBR) agonist bispecific antibodies for induction of tertiary lymphoid structures in the treatment of solid tumors” is being presented as part of the “Late-Breaking Research: Immunology 2” poster session (9:00 a.m. – 12:30 p.m. PT, poster section 52; board number 11).

Key Points: 
  • The poster titled “Conditionally active, therapeutic lymphotoxin beta receptor (LTBR) agonist bispecific antibodies for induction of tertiary lymphoid structures in the treatment of solid tumors” is being presented as part of the “Late-Breaking Research: Immunology 2” poster session (9:00 a.m. – 12:30 p.m. PT, poster section 52; board number 11).
  • The presented data demonstrate that Mestag’s bispecific antibody co-engages fibroblast activated protein (FAP) and LTBR to conditionally activate LTBR and induce Tertiary Lymphoid Structures (TLS) in the tumor.
  • In vivo data showed potent monotherapy efficacy as well as tumor regression in combination with tumor antigen or a checkpoint inhibitor.
  • Ray Jupp, PhD, Chief Scientific Officer of Mestag Therapeutics, said, “TLS is an exciting new area of anti-cancer immunology.

Lightbridge Senior Executives Assume Key Positions in Prestigious Nuclear Energy Industry Groups

Retrieved on: 
Thursday, March 21, 2024
Program management, Conference, Growth, EAC, ANS, International Council, IAEA, Nuclear energy, LTBR, Safety, Conference of the parties, Summit

RESTON, Va., March 21, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced the appointments of senior Lightbridge executives within leading U.S. nuclear energy industry groups.

Key Points: 
  • RESTON, Va., March 21, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced the appointments of senior Lightbridge executives within leading U.S. nuclear energy industry groups.
  • Seth Grae, President and CEO of Lightbridge, has been appointed as the Chair of the American Nuclear Society’s (ANS) International Council.
  • Through educational programs, industry insights, and market intelligence, USNIC facilitates collaboration between legislators across political lines, promoting nuclear energy as a key component of a successful clean energy paradigm.
  • Mr. Grae discussed the growth and future prospects of nuclear power on the eve of the first-ever Nuclear Energy Summit in Brussels.

Lightbridge Achieves Critical Fabrication Development Milestone by Demonstrating the Extrusion Process for Uranium-Zirconium Samples

Retrieved on: 
Monday, March 18, 2024
Uranium, Idaho National Laboratory, Development, Zirconium, INL, Research, Engineering, Extrusion, LTBR, Safety, HALEU, DOE, Economics

Idaho National Laboratory (INL) has extruded coupon samples of Lightbridge Fuel™ material consisting of an alloy of depleted uranium and zirconium.

Key Points: 
  • Idaho National Laboratory (INL) has extruded coupon samples of Lightbridge Fuel™ material consisting of an alloy of depleted uranium and zirconium.
  • The extrusion process involves pressing a metallic alloy billet through a die.
  • The data will support fuel performance modeling and regulatory licensing efforts for the commercial deployment of Lightbridge Fuel.
  • “We are pleased to collaborate with Lightbridge in achieving this important milestone in their efforts to qualify Lightbridge fuel,” said Jess Gehin, INL associate laboratory director for Nuclear Science and Technology.

Lightbridge Announces Upcoming Nuclear Events

Retrieved on: 
Wednesday, March 13, 2024
Physics, Government, Organization, Conference, University, International Atomic Energy Agency, Economic development, COP28, IAEA, Nuclear energy, LTBR, Summit, Renewable energy

RESTON, Va., March 13, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that Lightbridge President and CEO Seth Grae will participate in a series of upcoming nuclear events.

Key Points: 
  • RESTON, Va., March 13, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that Lightbridge President and CEO Seth Grae will participate in a series of upcoming nuclear events.
  • IAEA Nuclear Energy Summit 2024, Brussels, Belgium – Thursday, March 21
    World leaders will gather in Brussels at the first ever Nuclear Energy Summit to highlight the role of nuclear energy in addressing the global challenges to reduce the use of fossil fuels, enhance energy security and boost economic development.
  • The conference aims to provide a platform for international experts from vendors, utilities, research laboratories, and universities to exchange ideas and latest developments on a wide spectrum of topics.
  • For more information on the panel, visit: https://www.ans.org/meetings/physor2024/session/view-2379/

Mestag Therapeutics’ M300 Program, Designed to Conditionally Induce Tertiary Lymphoid Structures in Tumors, Selected for Late-Breaking Poster Presentation at AACR Annual Meeting

Retrieved on: 
Tuesday, March 5, 2024
LTBR, Patient, Therapy, AACR

CAMBRIDGE, United Kingdom, March 05, 2024 (GLOBE NEWSWIRE) -- Mestag Therapeutics (“Mestag”), a biotech company harnessing new insights into fibroblast-immune interactions to develop impactful treatments for patients, today announced the acceptance of a late-breaking abstract titled “Conditionally active, therapeutic lymphotoxin beta receptor (LTBR) agonist bispecific antibodies for induction of tertiary lymphoid structures in the treatment of solid tumors” for presentation at the American Association for Cancer Research (AACR) meeting taking place April 5-10, 2024 in San Diego, CA.

Key Points: 
  • CAMBRIDGE, United Kingdom, March 05, 2024 (GLOBE NEWSWIRE) -- Mestag Therapeutics (“Mestag”), a biotech company harnessing new insights into fibroblast-immune interactions to develop impactful treatments for patients, today announced the acceptance of a late-breaking abstract titled “Conditionally active, therapeutic lymphotoxin beta receptor (LTBR) agonist bispecific antibodies for induction of tertiary lymphoid structures in the treatment of solid tumors” for presentation at the American Association for Cancer Research (AACR) meeting taking place April 5-10, 2024 in San Diego, CA.

Lightbridge Provides Business Update and Announces Fiscal Year 2023 Financial Results

Retrieved on: 
Wednesday, February 28, 2024
GAIN, INL, Gateway, FEED, Centrus Energy, NuScale Power, ATM, Virginia Commonwealth University, Plant, COP28, Travel, Treasury, LTBR, Webcast, Texas A&M University, G&A, Research, Insurance, Structure, Cryptocurrency

RESTON, Va,, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results for the fiscal year ended December 31, 2023, and provided an update on the Company’s continued progress.

Key Points: 
  • RESTON, Va,, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results for the fiscal year ended December 31, 2023, and provided an update on the Company’s continued progress.
  • Cash provided by financing activities for the year ended December 31, 2023, was $6.2 million, a decrease of $4.7 million, compared to $10.9 million for the year ended December 31, 2022.
  • Stockholders’ equity was $28.9 million at December 31, 2023, as compared to $29.1 million at December 31, 2022.
  • This $0.4 million decrease was due to the GAIN voucher project that was completed in the first quarter of 2023.

Lightbridge CEO Seth Grae Issues Update Letter to Shareholders

Retrieved on: 
Tuesday, February 27, 2024
MOX, TRL, Uranium, NASA, Centrus Energy, FEED, NuScale Power, Nuclear Energy Agency, COP28, Letter, Plutonium, LTBR, Safety, Texas A&M University, Risk, DOE, Development, Technology readiness level, HALEU, Structure, Uranium mining

RESTON, Va., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today issued a corporate update in a letter to shareholders from President and CEO Seth Grae.

Key Points: 
  • RESTON, Va., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today issued a corporate update in a letter to shareholders from President and CEO Seth Grae.
  • Ms. Goodman, a recognized national security expert, joined Lightbridge as an independent director, bringing invaluable insights into the intersection of energy and national security.
  • Lightbridge is adopting the Technology Readiness Level (TRL) system to illustrate the progress of its fuel development efforts.
  • Currently, Lightbridge Fuel is positioned at TRL 4-5, indicating a significant phase in our development process.

Lightbridge to Hold Business Update & Fiscal Year 2023 Earnings Conference Call on Thursday, February 29 at 10 a.m. ET

Retrieved on: 
Thursday, February 22, 2024
LTBR, Webcast

Lightbridge will host a conference call on Thursday, February 29, at 10:00 AM ET with the investment community to discuss the Company’s financial results and provide an update on its fuel development activities.

Key Points: 
  • Lightbridge will host a conference call on Thursday, February 29, at 10:00 AM ET with the investment community to discuss the Company’s financial results and provide an update on its fuel development activities.
  • The conference call will be led by Seth Grae, President, and Chief Executive Officer, with other Lightbridge executives available to answer questions.
  • To access the call by phone, please register at this link ( registration link ), and you will be provided with dial-in details.
  • To avoid delays, we encourage participants to dial into the conference call fifteen minutes before the scheduled start time.

Lightbridge Announces Upcoming Industry Event and Media Interview

Retrieved on: 
Monday, January 22, 2024
BNN, BNN Bloomberg, Nuclear energy, LTBR, COP28, COP, Renewable energy

RESTON, Va., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that Lightbridge President and CEO Seth Grae will participate in upcoming industry and media events.

Key Points: 
  • RESTON, Va., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that Lightbridge President and CEO Seth Grae will participate in upcoming industry and media events.
  • Lightbridge President and CEO Seth Grae will be interviewed on BNN Bloomberg TV’s “The Street”, hosted by Paul Bagnell.
  • Lightbridge has released its latest newsletter , recapping the latest company developments and milestones, including coverage at COP 28.
  • The newsletter is available atop the Lightbridge home page at www.ltbridge.com .

Lightbridge and Centrus Energy Enter into a Contract to Conduct a FEED Study for a Lightbridge Pilot Fuel Fabrication Facility in Piketon, Ohio

Retrieved on: 
Thursday, December 7, 2023
COP28, Partnership, FEED, LTBR, Nuclear energy, HALEU

RESTON, Va. and BETHESDA, Md., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR) and Centrus Energy Corp. (“Centrus”) (NYSE American: LEU) today announced a contract to conduct a front-end engineering and design (FEED) study to add a dedicated Lightbridge Pilot Fuel Fabrication Facility (LPFFF) at the American Centrifuge Plant in Piketon, Ohio.

Key Points: 
  • RESTON, Va. and BETHESDA, Md., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR) and Centrus Energy Corp. (“Centrus”) (NYSE American: LEU) today announced a contract to conduct a front-end engineering and design (FEED) study to add a dedicated Lightbridge Pilot Fuel Fabrication Facility (LPFFF) at the American Centrifuge Plant in Piketon, Ohio.
  • The FEED study will identify infrastructure and licensing requirements as well as the estimated cost and construction schedule for the LPFFF.
  • Centrus’ wholly-owned subsidiary, American Centrifuge Operating, LLC, will lead the study, which is expected to be completed in 2024.
  • We are thrilled to partner with Centrus, leveraging their deep expertise and infrastructure to bring this vision to life.”